Happy New Year. They say it is not a good time for value investors because the glamour shares and new concept stocks are racing away in a bull market. But I’m not disappointed with my companies. They are generally performing well, much better than Mr Market thought they would when I bought them. Also, when the bear market does finally arrive I think I’ll weather it quite well with this solid bunch possessing limited downside risk.
In the tables below I present the returns after taking the hit on broker costs, stamp duty and bid/offer spread.
You can download the Newsletters I wrote at the time of purchase to read the logic behind the decision.
(Some of you have joined us recently so, in case you are not familiar with them, I briefly describe the criteria for my portfolios following the portfolio performance tables.)
The 2013 NCAV portfolio
Company | Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 |
French Con. | 25.7.13 | £0.3047 | zero | Sold July 2015 £0.4378 | 44% |
Caledonian T | 25.7.13 | £0.70 | zero | £1.40 | 100% |
Fletcher King | 6.8.13 | £0.30 | 14.25p | Sold June 2016 for 46p | 101% |
Northamber | 22.8.13 | £0.287 | 1.6p | Sold Oct 2016 £0.303 | 11% |
Titon | 5.9.13 | £0.379 | 6.5p | Sold May 2016 £1.06 | 197% |
Mallett | 12.11.13 | £0.7682 | 12.7p | Sold Nov 2014 £0.60 | -5% |
AVERAGE | 75% |
The 2014 NCAV portfolio
Company | Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 |
Holders Tech | 10.10.14 & 3.11.14 | £0.47 | 1p | Sold March 2017 £0.33 | -28% |
Airea | 4.11.14 | £0.1195 | 0.9p | Sold Sept 2016 £0.309 | 166% |
Northamber | 17.11.14 | £0.4265 | 0.7p | Sold Oct 2016 £0.303 | -27% |
Caledonian T | 30.12.14 | £1.39 | zero | £1.40 | 1% |
AVERAGE | 28% |
The 2015 NCAV portfolio
Company | Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 |
PV Crystalox | 15.1.15 | £0.122 | zero | Sold Dec 2016 £0.237 | 94% |
Arden Partners | 1.9.15 | £0.422 | zero | £0.52 | 23% |
Northamber | 4.9.15 | £0.443 | 0.4p | Sold Dec 2016 £0.303 | -31% |
AVERAGE | 29% |
The Buffett-style portfolio
This type of share is rarer than the others, and so I will combine all years. Unfortunately I have only one company so far – I’m working on it though.
Company | Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 |
Dewhurst | 9.4.14 | £3.18 | 36.5p | £5.20 | 75% |
AVERAGE | 75% |
(I bought some more of Dewhurst in June 2014 at £3.11, December 2014 at £3.75 and November 2017 at £5.46).
Modified price earnings ratio portfolio 2015/16
Company | Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 |
Haynes | 11.2.15 | £1.159 | 22.5p | £1.90 | 83% |
AGA | 11.3.15 | £1.002 | zero | Taken over Jun 2015 £1.456 | 45% |
Hogg Robinson | 10.4.15 | £0.4709 | 2.37p | Sold Jun 2016 £0.656 | 44% |
MS International | 3.7.15 | £1.86 | 14.5p | £2.05 | 18% |
BHP Billiton | 24.9.15 | £10.43 | 87.21p | £15.27 | 55% |
TClarke | 5.11.15 | £0.7916 | 6.4p | £0.788 | 8% |
Premier Farnell | 8.4.16 | £1.222 | 3.6p | Taken over 20.6.16 £1.632 | 36% |
AVERAGE | 41% |
The AGA holding was doubled 30 April at a price of £0.9466.
Modified price earnings ratio portfolio 2017
Company | Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 |
Braemar | 28.6.17 | £2.848 | 10p | £2.68 | -2% |
Caffyns | 10.8.17 | £5.012 | zero | £4.26 | -15% |
Connect | 27.9.17 | £1.046 | zero | £1.10 | 5% |
MS Intern | 14.11.17 | £1.84 | zero | £2.05 | 11% |
AVERAGE | -1% |
The return reversal portfolio
Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 | |
Havelock Europa | 20.5.15 | £0.14609 | zero | Sold Dec 2016 £0.0915 | -37% |
AVERAGE | -37% |
The 2017/18 NCAV portfolio
Purchase date | Purchase price | Divs to 31 December 2017 | Price 31 December 2017 | Return to 31 December 2017 | |
Caledonian T | 7.11.17 | £1.23 | zero | £1.40 | 14% |
AVERAGE | 14% |
Brief description of criteria for the portfolios
Shares are allocated to portfolios designed around ideas flowing from research conducted over many years when my PhD students and I asked the question “what works in investment?”
These investigations were often inspired by the ideas of great investors such as Benjamin Graham.
More detail on these ideas is presented in earlier posts (if you put key words into the search box those Newsletters will appear).
Net current asset value, NCAV, criteria
- Current asset values are taken from the balance sheet (e.g. inventory, receivables and cash). From this total are deducted all the liabilities. Long term asset values are usually ignored (counted as zero). Usually, further deductions are made to reduce inventory and receivable values to give a conservative bias.
- Companies passing the quantitative test are also assessed qualitatively for business prospects, managerial ability/integrity and business stability.
Modified price earnings ratio criteria
- A cyclically-adjusted price to earnings ratio (CAPE) significantly below average. That is, a current share price divided by the earnings per share calculated as an average of eps over the last seven to ten years.
- A high Piotroski score. These nine factors indicate whether a company is strengthening its financial position and income flow.
- Finally, and crucially, the same qualitative criteria as for NCAV investing.
Buffett-style criteria
- A strong economic franchise,
- Managers of integrity and talent,
- Excellent accounting numbers, and
- A reasonable price.
(There is much more on this in my books The Financial Times Guide to Value Investing or The Great Investors or Warren Buffett’s letters)
Return reversal
- Rank all shares based on their returns over the past five years. Select only the worst 20% of performers – “the losers”.
- Examine each loser share using Piotroski criteria. Select only those with a high score.
- Ensure that the company has a market capitalisation below its net tangible asset value
Use the same qualitative screening criteria as for NCAV investing.
BTW: I was interviewed on Bloomberg Radio last week – they have posted an 8 minute podcast if you would like to hear it – https://www.bloomberg.com/news/audio/2017-12-29/arnold-buffet-investment-paragon .
………………To read more articles like this subscribe to my premium newsletter Deep Value Shares – click here http://newsletters.advfn.com/deepvalueshares/subscribe-1